233 related articles for article (PubMed ID: 2157464)
1. Plasma digitalis-like activity and cytosolic Ca2+ in essential hypertension.
Le Quan Sang KH; Pernollet MG; Meyer P; Devynck MA
Am J Hypertens; 1990 Mar; 3(3):171-5. PubMed ID: 2157464
[TBL] [Abstract][Full Text] [Related]
2. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
[TBL] [Abstract][Full Text] [Related]
3. Platelet 5-HT content and uptake in essential hypertension: role of endogenous digitalis-like factors and plasma cholesterol.
Guicheney P; Devynck MA; Cloix JF; Pernollet MG; Grichois ML; Meyer P
J Hypertens; 1988 Nov; 6(11):873-9. PubMed ID: 2853193
[TBL] [Abstract][Full Text] [Related]
4. A quantitative receptor assay for "digitalis-like" compounds in serum. Demonstration of raised concentrations in essential hypertension and correlation with arterial blood pressure.
Moreth K; Renner D; Schoner W
Klin Wochenschr; 1987 Feb; 65(4):179-84. PubMed ID: 3031360
[TBL] [Abstract][Full Text] [Related]
5. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiological role of digitalis-like substance in essential hypertension.
Saitoh S; Shimamoto K; Nakagawa M; Yamaguchi Y; Matsuda K; Kuroda S; Ura N; Iimura O
J Hypertens Suppl; 1988 Dec; 6(4):S360-2. PubMed ID: 2853746
[TBL] [Abstract][Full Text] [Related]
7. Circulating digitalis-like compounds in essential hypertension.
Devynck MA; Pernollet MG; Cloix JF; de The H; Kamal L; Elghozi JL; Rosenfeld J; Meyer P
Clin Exp Hypertens A; 1984; 6(1-2):441-53. PubMed ID: 6321068
[TBL] [Abstract][Full Text] [Related]
8. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
Balzan S; Montali U; Biver P; Ghione S
J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002
[No Abstract] [Full Text] [Related]
9. Endogenous digitalis-like factors in hypertension and chronic renal insufficiency.
Kelly RA; O'Hara DS; Mitch WE; Steinman TI; Goldszer RC; Solomon HS; Smith TW
Kidney Int; 1986 Nov; 30(5):723-9. PubMed ID: 3023736
[TBL] [Abstract][Full Text] [Related]
10. Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma.
Balzan S; Montali U; Genovesi-Ebert A; Biver P; Fantoni M; Ghione S
Clin Sci (Lond); 1989 Oct; 77(4):375-81. PubMed ID: 2553327
[TBL] [Abstract][Full Text] [Related]
11. Plasma endogenous sodium pump inhibitor in essential hypertension.
Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
[TBL] [Abstract][Full Text] [Related]
12. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
13. An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Meyer P
Can J Physiol Pharmacol; 1987 Aug; 65(8):1522-7. PubMed ID: 2825938
[TBL] [Abstract][Full Text] [Related]
14. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
15. Bile salts as endogenous digitalis like factors.
Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
[TBL] [Abstract][Full Text] [Related]
16. Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism.
Delva P; Degan M; Capra C; Fallo F; Mantero F; Menegazzi M; Lechi C; Steele A; Lechi A
Miner Electrolyte Metab; 1989; 15(5):315-20. PubMed ID: 2554104
[TBL] [Abstract][Full Text] [Related]
17. Endogenous digitalis-like compounds in essential and experimental hypertension.
Devynck MA; Pernollet MG; Meyer P
Int J Rad Appl Instrum B; 1987; 14(4):341-52. PubMed ID: 3654254
[TBL] [Abstract][Full Text] [Related]
18. Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly.
Deray G; Rieu M; Devynck MA; Pernollet MG; Chanson P; Luton JP; Meyer P
N Engl J Med; 1987 Mar; 316(10):575-80. PubMed ID: 3027557
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effect of canrenone in a model where endogenous ouabain-like factors are present.
de Mendonça M; Grichois ML; Pernollet MG; Wauquier I; Trouillet-Thormann B; Meyer P; Devynck MA; Garay R
J Cardiovasc Pharmacol; 1988 Jan; 11(1):75-83. PubMed ID: 2450260
[TBL] [Abstract][Full Text] [Related]
20. Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.
Graves SW; Eder JP; Schryber SM; Sharma K; Brena A; Antman KH; Peters WP
Clin Sci (Lond); 1989 Nov; 77(5):501-7. PubMed ID: 2555106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
